Histopathology of primary biliary cirrhosis with emphasis on expression of adhesion molecules

Seminars in Liver Disease

Volumn 17, Issue 1, 1997, Pages 35-47

  Nakanuma, Yasuni ^a   Yasoshima, Mitsue ^a   Tsuneyama, Kouichi ^a   Harada, Kenichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

B 7 family; epitheliotropism; intercellular adhesion molecules 1; vascular adhesion molecule 1; very late antigen family

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL MEDIATED CYTOTOXICITY; HISTOPATHOLOGY; HUMAN; INFLAMMATORY CELL; LIVER PARENCHYMA; LYMPHOCYTE FUNCTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0031004590     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007181     Document Type: Article

References (77)

1. Nakanuma Y, Tsuneyama K, Gershwin ME, et al: Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress. Sem Liver Dis 15: 313-28, 1995.
2. Gershwin ME, Mackay ER: Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 100.822-33, 1991.
3. Lim AG, Jazrawi RP, Levy JH, et al: Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis. J Hepatol 22:416-22, 1995.
4. Springer TA: Adhesion receptors of the immune system. Nature 346:425-34, 1990.
5. Anderson JA, Lentsch AB, Hadjiminas DJ, et al: The role of cytokines, adhesion molecules, chemokines in interleukin-2-induced lymphocytic infiltration in C57BL/6 mice. J Clin Invest 97:1952-9, 1996.
6. Volpes R, Van den Oord JJ, Desmet VJ: Distribution of the VLA family of integrins in normal and pathological human liver tissue. Gastroenterology 101:200-6, 1991.
7. Williams AF, Barclay AN: The immunoglobulin superfamily - domains for cell surface recognition. Ann Rev Immunol 6: 381-405, 1988.
8. Bevilacqua MP, Pober JS, Mendrick DL, et al: Identification of an inducible endothelial-leukocyte adhesion. Proc Natl Acad Sci USA 84:9238-42, 1987.
9. Hynes RO: Integrin: a family of cell surface receptors. Cell 48:549-54, 1987.
10. Yasoshima M, Nakanuma Y, Tsuneyama K, et al: Immunohistochemical analysis of adhesion molecules in the micro-environment of portal tracts in relation to aberrant expression of PDC-E2 and HLA-DR on the bile ducts in primary biliary cirrhosis. J Pathol 175:319-25, 1995.
11. Volpes R, Van Den Oord JJ, Desrnet VJ: Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 12:59-65, 1990.
12. Nakanuma Y, Harada K: Florid duct lesion in primary biliary cirrhosis shows highly proliferative activities. J Hepatol 19: 216-21, 1993.
13. Nakanuma Y, Ohta G: Quantitation of hepatic granulomas and epithelioid cells in primary biliary cirrhosis. Hepatology 3: 423-7, 1983.
14. Bernuau D, Feldman F, Degott C, et al: Ultrastructural lesions of bile ducts in primary biliary cirrhosis. A comparison with the lesions observed in graft-versus-host disease. Human Pathol 12:782-93, 1981
15. Nakanuma Y, Ohta G, Kono N, et al: Electron microscopic observation of destruction of biliary epithelium in primary biliary cirrhosis. Liver 3:238-48, 1983.
16. Nakanuma Y, Ohta G: Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 76:1326-32, 1979.
17. Terasaki S, Nakanuma Y, Yamazaki M, et al. Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphologic study. Hepatology 17:206-12, 1993.
18. Farrell DJ, Hines JE, Walls AF, et al: Intrahepatic mast cells in chronic liver diseases. Hepatology 22:1175-81, 1995.
19. Jorge AD, Stati AO, Roig LV, et al: Steroid receptors and heat-shock proteins in patients with primary biliary cirrhosis. Hepatology 18:1108-14, 1993.
20. Van de Water J, Thurchany J, Leung PSC, et al: Molecular mimicry in primary biliary cirrhosis. Evidence for biliary expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest 92:2653-64, 1993.
21. Ohnishi S, Maeda T, Iwasaki S, et al: A biliary protein identified by immunoblotting stimulates proliferation of peripheral blood T lymphocytes in primary biliary cirrhosis. Liver 11: 321-8, 1991.
22. Van de Water J, Ansari A, Prindiville T, et al: Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 181:723-33, 1995.
23. June CH, Bluestone JA, Nadler LM, et al: The B7 and CD28 receptor families Immunol Today 15:321-31, 1994.
24. Thompson CB: Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81:979-82, 1995.
25. Freeman GJ, Borriello F, Hodes JJ, et al: Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907-9, 1993.
26. Hathcock KS, Laszlo G, Pucillo C, et al: Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 180:631-40, 1994.
27. Henschow DJ, Su GH, Zuckerman LA, et al: Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci USA 90:11054-8, 1993.
28. Kearney ER, Pape KA, Loh DY, et al: Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327-39, 1994.
29. Bluestone JA: New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555-9, 1995.
30. Yamada G, Hyodo I, Kobe K: Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelium in primary biliary cirrhosis. Hepatology 6:385-91, 1986.
31. Patarrayo M, Makgoba MW: Leukocyte adhesion to cells in immune and inflammatory responses. Lancet 2:1139-42, 1989.
32. Broome U, Hultcrantz R, Scheynius A: Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis. Scand J Gastroenterol 28:126-30, 1993.
33. Nakanuma Y, Kono N: Expression of HLA-DR antigens on interlobular bile ducts in primary biliary cirrhosis and other hepatobiliary diseases: An immunohistochemical study. Human Path 22:431-6, 1991.
34. Adams DH, Hubscher SG, Shaw J, et al: Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 14:426-31, 1991.
35. Essani NA, Fisher MA, Farhood A, et al: Cytokine-induced hepatic intercellular adhesion molecule-1 (ICAM-1) mRNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology 55:105-11, 1995.
36. Ayres RCS, Neuberger JM, Shaw J, et al: Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of proinflammatory cytokines. Gut 34:1245-9, 1993.
37. Jaeschke H, Essani NA, Fisher MA, et al: Release of soluble intercellular adhesion molecule 1 into bile and serum in murine endotoxin shock. Hepatology 23:530-6, 1996.
38. Kaji K, Nakanuma Y, Saski M, et al: Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies. Modern Pathol 7:937-45, 1994.
39. Demetris AJ, Sever C, Kakizoe S, et al: S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases: relevance to pathogenesis. Am J Pathol 134:741-7, 1989.
40. Leon MP, Kirby JA, Gibbs P, et al: Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. J Hepatol 22:591-5, 1995.
41. Garcia-Monzon C, Sanchez-Madrid F, Carcia Buely L, et al: Vascular adhesion molecule expression in viral hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 9:211-20, 1994.
42. Nakanuma Y: Distribution of B lymphocytes in nonsuppurative destructive cholangitis in primary biliary cirrhosis. Hepatology 18:570-5, 1993.
43. Leon MP, Bassendine MF, Wilson JL, et al: Immunogenicity of biliary epithelial cells: investigation of antigen presentation to CD4+ T cells. Hepatology 24:561-7, 1996.
44. Yamada G, Hyodo I, Tobe K, et al: Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis. Hepatology 6:385-91, 1986.
45. Koga S, Sakisaka M, Ohishi M, et al: Nuclear DNA fragmentation in biliary epithelial cells and in hepatocytes in primary biliary cirrhosis. Hepatology 22:121A. Abstract.
46. Kishi K, Yamada G, Tsugeno H, et al: Immunohistochemical study of Fas in the liver of primary biliary cirrhosis, Hepatology 22:438A. Abstract.
47. Hiramatsu N, Hayashi N, Katayama K, et al: Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354-9, 1994.
48. Kobayashi S, Nakanuma Y, Matsui O: Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: A histologic study. Hum Pathol 25:940-6, 1994.
49. Vierling JM, Emmett M, Howell CD, et al: Immunogeneity of isolated bile duct epithelial cells (BDC) in mice exhibiting nonsuppurative destructive cholangitis (NSDC) during chronic graft-vs-host disease (CGVHD). Hepatology 10:584. Abstract.
50. Adams DH, Shaw S: Leukocyte-endothelial interactions and regulation of leukocyte migration. Lancet 343:831-5, 1994.
51. Steinhoff G, Behrend M, Schrader B, et al: Intercellular immune adhesion molecules in human liver transplants: overview on expression patterns of leukocyte receptor and ligand molecules. Hepatology 18:440-53, 1993.
52. Hemler ME, Elices MJ, Parker C, et al: Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev 114:45-65, 1990.
53. Hogg N, Landis RC: Adhesion molecules in cell interactions. Curr Opin Immunol 5:383-90, 1993.
54. Shimizu Y, Newman W, Tanaka Y, et al: Lymphocyte interactions with endothelial cells. Immunol Today 13:106-12, 1992.
55. Jaspars LH, Beljaards RC, Bonnet P, et al: Distinctive adhesion pathways are involved in epitheliotrophic processes at different sites. J Pathol 178:385-92, 1996.
56. Matsumoto A, Hemler ME: Multiple activation state of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J Cell Biol 268: 228-234, 1993.
57. Wayner EA, Garcia-Pando A, Humphries MJ, et al: Identification and characterization of the lymphocyte receptor for an alternative cell attachment (CS1) in plasma fibronectin. J Cell Biol 109:1321-30, 1989.
58. Mosnier JF, Scoazec JY, Marcellin P, et al: Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C Gastroenterology 107:1457-68, 1994.
59. Popper H: The problem of histologic evaluation of primary biliary cirrhosis. Virchow Archiv A 379:99-102, 1978.
60. Nakanuma Y, Saito K, Unoura M: Semiquantitative assessment of cholestasis and lymphocytic piecemeal necrosis in primary biliary cirrhosis: A histologic and immunohistochemical study. J Clin Gastroenterol 12:357-62, 1990.
61. Nakanuma Y: Necroinflammatory changes in hepatic lobules in primary biliary cirrhosis with less well-defined cholestatic changes. Human Pathol 24:378-83, 1993.
62. Nakanuma Y, Ohta G: Immunohistochemical study on bile ductular proliferation in various hepatobiliary diseases. Liver 6: 205-11, 1986
63. Portmann BC, Popper H, Neuberger J, et al: Sequential and diagnostic features of primary biliary cirrhosis based on serial histologic study in 209 cases. Gastroenterology 88:1777-90, 1985.
64. Lohr H, Treichel U, Poralla T, et al: The human hepatic asialo-glycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatology 12:1314-20, 1990.
65. Bathal PS, Gall JA: Deletion of hyperplastic biliary epithelial cells by apoptosis following removal of the proliferative stimuli Liver 5:311-25, 1985.
66. Babbs C, Haboubi N, Meller JM, et al: Endothelial cell transformation in primary biliary cirrhosis: a morphologic and biochemical study. Hepatology 11:723-9, 1990.
67. Mathew J, Hines JE, Toole K, et al: Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis. Histopathology 25:65-70, 1994.
68. Calmus Y, Gane P, Rouger P, et al. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 11:12-15, 1990.
69. Terasaki T, Nakanuma Y, Ogino H, et al: Hepatocellular and biliary expression of HLA antigen in primary biliary cirrhosis before and after ursodeoxycholic acid therapy. Am J Gastroenterol 86:1194-9, 1991.
70. Tanaka H, Hirano N, Miura T, et al: Mechanism of UDCA action on hepatobiliary diseases. Kan-Tan-Sui 31:969-75, 1995 (in Japanese).
71. Kurktschiev D, Subat S, Adler D, et al: Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. J Hepatol 18:373-7, 1993.
72. Adams DH, Mainolfi E, Burra P, et al: Detection of circulating intercellular adhesion molecule-1 in chronic liver disease. Hepatology 16:810-4, 1992.
73. Lim AG, Jazrawi RP, Levy JH, et al: Soluble E-selectin and vascular adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis. J Hepatol 22:416-22, 1995.
74. Banks RE, Gearing AH, Hemingway IK, et al: Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 68:122-4, 1993.
75. Leuwenberg JFM, Smeets EFM, Neefjes JJ, et al: E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells. Biochem Biophys Res Commun 187:584-9, 1992.
76. Gearing AJH, Newman W: Circulating adhesion molecules in disease. Immunol Today 14:506-12, 1993.
77. Harada K, Terada T, Nakanuma Y: Distribution of transforming growth factor-alpha protein and mRNA in hepatobiliary diseases by immunohistochemical and in situ hybridization techniques. Human Pathol 27:787-92, 1996.